Leukemia veröffentlicht präklinische Entwicklungsergebnisse der CAR-T-Therapie GYA01 für akute myeloische Leukämie (AML) und T-Zell-akute lymphoblastische Leukämie (T-ALL) Gyala sichert sich

Leukemia publishes preclinical development results of CAR-T therapy GYA01 for acute myeloid leukemia (AML) and T-cell acute lymphoblastic leukemia (T-ALL)

LANCASTER, S.C., Sept. 15, 2025 /PRNewswire/ -- Get ready for another unforgettable year of A Different Way to CE™! Since

The company is focusing on its European operations. EY advised Statkraft, and Standard Chartered advised Serentica.

The company is collaborating with technology providers and state governments to explore individual nuclear projects, Singh has said.